Skip to main content
. 2024 Nov 14;5(6):1201–1214. doi: 10.1002/jha2.1046

TABLE 2.

Univariate analysis of clinical factors and neuroinflammation‐related gene expressions in the discovery cohort.

Variable Group Univariate analysis
n 2 years OS, % Median, years p‐value
Clinical factors
Age, years ≤70 16 50 1.86 0.965
>70 14 50 2.36
KPS <70 23 34.8 1.14 0.0362
≥70 7 100 NA
Sex Male 19 52.6 2.62 0.518
Female 11 45.5 1.73
LDH > upper limit Low 16 62.5 3.04 0.431
High 14 35.7 1.16
Consciousness levels at diagnosis No 11 72.7 3.19 0.127
Yes 19 36.8 0.93
Involvement of deep brain No 8 62.5 2.5 0.902
Yes 22 45.5 1.53
Cell of origin Non‐GCB 24 50 1.86 0.353
GCB 6 50 1.73
Gene expressions
SOX10 Low 8 75 3.03 0.0438
High 22 40.9 0.89
MOG Low 5 100 NA 0.0396
High 25 40 1.17
MAG Low 7 85.7 NA 0.0248
High 23 39.1 1.17
GJB1 Low 5 80 NA 0.0448
High 25 44 1.35
MAL Low 8 75 NA 0.0438
High 22 40.9 1.26
PLXNB3 Low 7 71.4 NA 0.0444
High 23 43.5 1.35
S100B Low 8 68.2 3.03 0.00569
High 22 0 0.89
PMP22 Low 8 75 NA 0.0462
High 22 40.9 1.26
MYRF Low 13 69.2 NA 0.0311
High 17 35.2 1.17
TMC7 Low 6 83.3 NA 0.0326
High 24 41.7 1.26
PLEKHB1 Low 8 75 NA 0.0478
High 22 40.9 1.26
SLC6A1 Low 5 60 2.99 0.0042
High 25 0 0.73
MAPT Low 12 66.7 3.19 0.0112
High 18 25 1.03
TUBB4A Low 8 63.6 3.03 0.00663
High 22 11.7 0.89
GRM3 Low 8 59.1 2.83 0.0411
High 22 25 0.99
ERBB3 Low 10 70 NA 0.0287
High 20 40 1.26
NLGN2 Low 11 63.2 3.19 0.0183
High 19 27.3 1.14
DST Low 12 66.7 3.03 0.0273
High 18 25 0.89
GJA1 Low 11 63.2 2.99 0.0231
High 19 27.3 0.93

Abbreviation: KPS, Karnofsky performance status.